TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -45.46%27.67M | -44.63%90.98M | -46.66%50.73M | -48.74%164.31M | -36.06%95.11M | -1.76%320.52M | 34.70%148.74M | -12.87%326.25M | -36.02%110.43M | -12.33%374.44M |
Operating income | -45.46%27.67M | -44.63%90.98M | -46.66%50.73M | -48.74%164.31M | -36.06%95.11M | -1.76%320.52M | 34.70%148.74M | -12.87%326.25M | -36.02%110.43M | -12.33%374.44M |
Cost of sales | 39.62%-34.66M | 14.91%-181.43M | 42.75%-57.4M | 26.01%-213.22M | 17.54%-100.26M | 9.16%-288.19M | -6.09%-121.58M | 3.95%-317.23M | 29.11%-114.6M | 20.32%-330.29M |
Operating expenses | 39.62%-34.66M | 14.91%-181.43M | 42.75%-57.4M | 26.01%-213.22M | 17.54%-100.26M | 9.16%-288.19M | -6.09%-121.58M | 3.95%-317.23M | 29.11%-114.6M | 20.32%-330.29M |
Gross profit | -4.86%-6.99M | -84.90%-90.44M | -29.45%-6.66M | -251.28%-48.91M | -118.96%-5.15M | 258.43%32.33M | 750.11%27.16M | -79.57%9.02M | -138.22%-4.18M | 251.67%44.15M |
Selling expenses | 29.61%-5.35M | 44.69%-14.62M | ---7.61M | ---26.44M | ---- | ---- | ---- | ---- | ---- | ---- |
Administrative expenses | 11.44%-19.13M | 4.92%-45.82M | ---21.6M | ---48.19M | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus | -653.65%-70.29M | -270.77%-12.05M | 78.96%-9.33M | -112.20%-3.25M | -277.33%-44.32M | -56.41%26.63M | 362.27%25M | 128.55%61.09M | -22.04%5.41M | -70.61%26.73M |
-Changes in the fair value of other assets | -653.65%-70.29M | -270.77%-12.05M | 78.96%-9.33M | -112.20%-3.25M | -277.33%-44.32M | -56.41%26.63M | 362.27%25M | 128.55%61.09M | -22.04%5.41M | -70.61%26.73M |
Impairment and provision | -159.33%-528K | -95.76%1.06M | -96.48%890K | 1,632.72%24.92M | 20,665.85%25.3M | -118.68%-1.63M | -104.31%-123K | 104.01%8.71M | -25.21%2.86M | 112.14%4.27M |
-Other impairment is provision | -159.33%-528K | -95.76%1.06M | -96.48%890K | 1,632.72%24.92M | 20,665.85%25.3M | -118.68%-1.63M | -104.31%-123K | 104.01%8.71M | -25.21%2.86M | 112.14%4.27M |
Special items of operating profit | -1,067.55%-15.41M | -23.31%1.71M | 277.49%1.59M | 96.74%2.23M | 36.57%422K | -67.99%1.13M | -81.44%309K | 102.00%3.54M | 269.18%1.67M | -337.08%-177.56M |
Operating profit | -175.57%-117.7M | -60.75%-160.17M | -79.81%-42.71M | -270.40%-99.64M | -145.39%-23.75M | -29.00%58.47M | 809.87%52.34M | 180.41%82.36M | -74.01%5.75M | -13.26%-102.42M |
Financing cost | -7.17%-12.12M | -39.15%-23.81M | -54.68%-11.31M | -5.79%-17.11M | 6.36%-7.31M | 8.36%-16.17M | 13.95%-7.81M | 27.96%-17.65M | 25.78%-9.08M | -10.73%-24.5M |
Share of profits of associates | 29.17%-34K | -37.70%-84K | 9.43%-48K | 50.81%-61K | 22.06%-53K | -214.81%-124K | 59.76%-68K | --108K | ---169K | ---- |
Special items of earning before tax | ---- | ---- | ---- | ---- | -1.56%-41.51M | 3.27%-91.68M | -8.42%-40.88M | 34.36%-94.77M | 29.12%-37.7M | ---144.37M |
Earning before tax | -140.16%-129.85M | -57.57%-184.06M | 25.56%-54.07M | -135.97%-116.81M | -2,127.69%-72.63M | -65.26%-49.5M | 108.70%3.58M | 88.96%-29.95M | 4.83%-41.2M | -141.03%-271.29M |
Tax | 354.16%16.58M | 132.84%44.38M | -59.98%3.65M | 295.91%19.06M | 288.18%9.12M | -57.60%-9.73M | -195.23%-4.85M | -114.30%-6.17M | 60.26%5.09M | 475.47%43.17M |
After-tax profit from continuing operations | -124.67%-113.27M | -42.89%-139.67M | 20.62%-50.42M | -65.03%-97.75M | -4,920.63%-63.51M | -63.95%-59.23M | 96.50%-1.27M | 84.16%-36.13M | 9.98%-36.11M | -117.15%-228.12M |
Earning after tax | -124.67%-113.27M | -42.89%-139.67M | 20.62%-50.42M | -65.03%-97.75M | -4,920.63%-63.51M | -63.95%-59.23M | 96.50%-1.27M | 84.16%-36.13M | 9.98%-36.11M | -117.15%-228.12M |
Minority profit | -111.35%-19.37M | -57.46%-46.6M | 24.26%-9.16M | -32.75%-29.59M | -18.77%-12.1M | -18.01%-22.29M | 13.54%-10.19M | 77.59%-18.89M | 33.36%-11.78M | -75.02%-84.31M |
Profit attributable to shareholders | -127.63%-93.91M | -36.57%-93.08M | 19.76%-41.25M | -84.50%-68.15M | -676.16%-51.41M | -114.29%-36.94M | 136.69%8.92M | 88.01%-17.24M | -8.45%-24.32M | -152.84%-143.81M |
Basic earnings per share | -131.82%-0.051 | -35.14%-0.05 | 21.43%-0.022 | -85.00%-0.037 | -660.00%-0.028 | -122.22%-0.02 | 138.46%0.005 | 88.46%-0.009 | -8.33%-0.013 | -151.61%-0.078 |
Diluted earnings per share | -660.00%-0.028 | -122.22%-0.02 | 138.46%0.005 | 88.46%-0.009 | -8.33%-0.013 | -151.61%-0.078 | ||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.